Zobrazeno 1 - 10 of 710 pro vyhledávání: '"telitacicept"'
1
Akademický článek
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study.
Autor: Wang, Meng1 (AUTHOR), Ma, Jianfei1 (AUTHOR), Yao, Li1 (AUTHOR) liyao_cmu@163.com, Fan, Yi1 (AUTHOR) cmu20200520@163.com
Publikováno v: Clinical Kidney Journal. Oct2024, Vol. 17 Issue 10, p1-10. 10p.
Zobrazit plný text záznamu
2
Akademický článek
Single‐dose telitacicept therapy for refractory idiopathic membranous nephropathy: A case series.
Autor: Sun, Liping1,2 (AUTHOR) slp08@126.com, Chen, Fuce1,2 (AUTHOR), Zhang, Xinzhou1,2 (AUTHOR)
Publikováno v: Clinical Case Reports. Nov2024, Vol. 12 Issue 11, p1-9. 9p.
Zobrazit plný text záznamu
3
Akademický článek
Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review.
Autor: Fan, Qiuyu1 (AUTHOR), Ji, Hongyan2 (AUTHOR), Liu, Ya1 (AUTHOR), Jia, Chao1 (AUTHOR), Zou, Liang1 (AUTHOR), Yang, Huiqin1 (AUTHOR) yanghuiqin2460@163.com
Publikováno v: Lupus. Apr2024, Vol. 33 Issue 4, p414-419. 6p.
Zobrazit plný text záznamu
4
Akademický článek
Telitacicept Treatment Refractory Lupus Nephritis: A Case Report.
Autor: Li, Sijia1 (AUTHOR), Deng, Shuting2 (AUTHOR), Wen, Sichun1 (AUTHOR), Peng, Siqi1 (AUTHOR), Jiang, Nan1 (AUTHOR), Li, Bohou1 (AUTHOR), Chen, Boxi1 (AUTHOR), Yuan, Ye1 (AUTHOR), Wu, Qiong1 (AUTHOR), Tao, Yiming1 (AUTHOR), Ma, Jianchao1 (AUTHOR), Lin, Ting1 (AUTHOR), Wen, Feng1 (AUTHOR), Li, Zhuo1 (AUTHOR), Dai, Hao1 (AUTHOR), Huang, Renwei1 (AUTHOR), Feng, Zhonglin1 (AUTHOR), Li, Zhilian1 (AUTHOR), Liu, Shuangxin1 (AUTHOR), Xu, Lixia1 (AUTHOR)
Publikováno v: Case Reports in Nephrology & Dialysis. Jan-Dec2024, Vol. 14 Issue 1, p42-47. 6p.
Zobrazit plný text záznamu
5
Akademický článek
Successful pregnancy in a patient with IgA nephropathy treated with telitacicept: a case report.
Autor: Du, Xinru1 (AUTHOR), Tian, Geng2 (AUTHOR), Lu, Xuehong1 (AUTHOR) luxueh@jlu.edu.cn
Publikováno v: BMC Pregnancy & Childbirth. 6/17/2024, Vol. 24 Issue 1, p1-7. 7p.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Safety and efficacy of telitacicept in refractory systemic lupus erythematosus patients who failed treatment with belimumab : A case series.
Autor: Fan Q; Department of Rheumatology, No.1 Hospital of Wuhan, No. 215, Zhongshan Avenue, Wuhan, Hubei Province, China. 976727692@qq.com., Yang H; Department of Rheumatology, No.1 Hospital of Wuhan, No. 215, Zhongshan Avenue, Wuhan, Hubei Province, China., Liu Y; Department of Rheumatology, No.1 Hospital of Wuhan, No. 215, Zhongshan Avenue, Wuhan, Hubei Province, China.
Publikováno v: Zeitschrift fur Rheumatologie [Z Rheumatol] 2024 Jun; Vol. 83 (5), pp. 387-392. Date of Electronic Publication: 2023 Dec 29.
Zobrazit plný text záznamu
8
Akademický článek
Single‐dose telitacicept therapy for refractory idiopathic membranous nephropathy: A case series
Autor: Liping Sun, Fuce Chen, Xinzhou Zhang
Publikováno v: Clinical Case Reports, Vol 12, Iss 11, Pp n/a-n/a (2024)
Key Clinical Message We report three cases of IMN from our center, where patients received a single dose of telitacicept after showing no response to conventional treatments. Although one case did not respond, the other two cases achieved complete or
Externí odkaz: https://doaj.org/article/0208072f3f464451bb3932e4ca065225
Zobrazit plný text záznamu
9
Akademický článek
Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report.
Autor: Huang, Li1 (AUTHOR), Qian, Gangzhen2 (AUTHOR), Zhang, Huhai1 (AUTHOR), Li, Qixuan1 (AUTHOR), Chen, Liping1 (AUTHOR), Tang, Xiaopeng1 (AUTHOR) txp12002@163.com, Zhao, Hongwen1 (AUTHOR) zhaohw212@126.com
Publikováno v: Lupus. Feb2024, Vol. 33 Issue 2, p172-175. 4p.
Zobrazit plný text záznamu
10
Akademický článek
Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review
Autor: Jia Wang, Haotao Zheng, Jia Wei, Jiaping Wu, Ziyang Feng, Xueqin Chen, Yangsicheng Liu, Wenxin Qin, Xiude Qin, Fanxin Kong
Publikováno v: Frontiers in Immunology, Vol 15 (2024)
Muscle-specific kinase (MuSK) myasthenia gravis (MG) is relatively rare and has a higher incidence of myasthenic crisis compared with other subtypes. However, there is still a lack of effective treatment for refractory MuSK MG. We report the case of
Externí odkaz: https://doaj.org/article/c2bed5ff8abd4d97bdfcf6c58e9aa07b
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje